Stein Holst Annexstad
Chief Executive Officer at Holstein AS
Network origin in Stein Holst Annexstad first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
Norwegian School of Economics & Business Administration
7
| College/University | Other Consumer Services | 7 |
Holstein AS
 Holstein AS Financial ConglomeratesFinance Holstein AS engages in the production, trade, investment, and consultancy services. It is also involved in financing and shipping activities. The company was founded on April 26, 1990 and is headquartered in Asker, Norway.
4
| Private Company | Financial Conglomerates | 4 |
NorgesInvestor Formuesforvaltning AS
 NorgesInvestor Formuesforvaltning AS Investment ManagersFinance NorgesInvestor Formuesforvaltning AS is a group of companies that focuses on strategic and financial value development. The private company's investment arm, NorgesInvestor Proto, invests in companies listed on the Oslo Stock Exchange. The company is based in Oslo, Norway. and has subsidiaries in Norway and Sweden. The Norwegian company was founded in 1996 by Jan Gunnar Hartvig, Stein Holst Annexstad. The CEO is Øivind E. Hermansen.
1
| Private Company | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stein Holst Annexstad via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CONOCOPHILLIPS | Oil & Gas Production | Director/Board Member | |
| TELENOR ASA | Major Telecommunications | Chairman Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Director/Board Member | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
| THERACRYF PLC | Medical/Nursing Services | Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| Oxford Brookes University | College/University | Masters Business Admin Graduate Degree | |
Norkart AS
 Norkart AS Engineering & ConstructionIndustrial Services Norkart AS offers and trades digital mapping and software in the fields of geographical information and municipal engineering technology. Its products include GISLINE, KOMTEK, and WEBATLAS. The company was founded in 1961 and is headquartered in Sandvika, Norway. | Engineering & Construction | Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
| Norwegian University of Science & Technology | College/University | Graduate Degree | |
| University of Bergen | College/University | Undergraduate Degree | |
| London Business School | College/University | Masters Business Admin | |
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Boostcom Group AS
 Boostcom Group AS Packaged SoftwareTechnology Services Boostcom Group AS operates databases and offers short messaging system. The company was founded by Øystein Robertsen Skiri on June 30, 2000 and is headquartered in Trondheim, Norway. | Packaged Software | Director/Board Member | |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Havila Ariel AS
 Havila Ariel AS Financial ConglomeratesFinance Havila Ariel AS engages in the development and investment in other companies. The company was founded on April 16, 2007 and is headquartered in Fosnavåg, Norway. | Financial Conglomerates | Director/Board Member | |
Kantega AS
 Kantega AS Miscellaneous Commercial ServicesCommercial Services Kantega AS provides IT consulting services. It offers design, development, and the integration of applications for companies that require out sourcing services, as well as consultation and maintenance. The company was founded in 2003 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | President | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Private Equity Investor | |
Numascale AS
 Numascale AS Computer Processing HardwareElectronic Technology Numascale AS provides a range of shared-memory server systems solutions and appliances. Its NumaConnect technology enables computer system vendors to build scalable system and allows high volume manufactured server boards to be used as building blocks for systems. The firm's product enables applications to scale beyond a single main board and includes support for virtualization of processing, memory, and input-output resources and can be used with standard operating systems. The company was founded by Einar Rustad and Kåre Løchsen in 2008 and is headquartered in Oslo, Norway. | Computer Processing Hardware | Director/Board Member | |
| Baxter Medical AB | Corporate Officer/Principal | ||
| University of Kent | College/University | Undergraduate Degree | |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Biotechnology | Founder | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
| West Thorpe (2011) Ltd. | Director/Board Member | ||
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
| Tappin AS | Director/Board Member | ||
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Investment Officer | |
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Norway | 21 |
| United Kingdom | 15 |
| Sweden | 7 |
| United States | 5 |
| Netherlands | 3 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 6 |
| Energy Minerals | 2 |
Operational
| Director/Board Member | 100 |
| Chairman | 42 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 22 |
| Chief Tech/Sci/R&D Officer | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Susan Foden | 32 |
| Svein Aaser | 24 |
| Harald Johan Norvik | 21 |
| Hilde Furberg | 21 |
| Jon-Øyvind Eriksen | 16 |
| Ole Melberg | 14 |
| Kari Grønås | 12 |
| Dominic Smethurst | 11 |
| Debra Stephanie Barker | 11 |
| Alan Barge | 10 |
| Anthony Brown | 10 |
| Pamela A. Trail | 8 |
| Martin Ove Todnem | 6 |
| Debbie Molyneux | 5 |
| Nils Petter Skaset | 5 |
- Stock Market
- Insiders
- Stein Holst Annexstad
- Company connections
